MedPath

Oxacillin

Oxacillin for Injection, USP

Approved
Approval ID

152758c0-d225-4761-abeb-3f1cb0190806

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 10, 2022

Manufacturers
FDA

Eugia US LLC

DUNS: 968961354

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Oxacillin Sodium

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code55150-129
Application NumberANDA201538
Product Classification
M
Marketing Category
C73584
G
Generic Name
Oxacillin Sodium
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateFebruary 2, 2023
FDA Product Classification

INGREDIENTS (2)

OXACILLIN SODIUMActive
Quantity: 10 g in 100 mL
Code: G0V6C994Q5
Classification: ACTIM
SODIUM PHOSPHATE, DIBASICInactive
Code: GR686LBA74
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Oxacillin - FDA Drug Approval Details